A Haynes and Boone, LLP deal team represented BioSig Technologies, Inc. (Nasdaq: BSGM) in a $17.5 million registered direct offering of its common stock, which closed on June 26, 2020.
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiogram (ECG) and intra-cardiac signals.
New York Partner Rick Werner, co-chair of Haynes and Boone’s Capital Markets and Securities Practice Group, and Jayun Koo, a partner in the New York Capital Markets and Securities Practice Group, led the team representing BioSig. They were assisted by New York Associate Eloise Rotenberg.
Haynes and Boone’s Capital Markets and Securities Practice Group delivers strategic solutions and provides comprehensive advice on a full range of securities transactions and reporting matters. The group has helped companies raise capital and comply with evolving securities laws and practices for more than four decades, and it serves as securities counsel to more than 30 public companies ranging in size from small cap companies to large cap multi-national business entities.
Haynes and Boone is an international corporate law firm with offices in Texas, New York, California, Charlotte, Chicago, Denver, Washington, D.C., London, Mexico City and Shanghai, providing a full spectrum of legal services in energy, technology, financial services and private equity. With more than 575 lawyers, Haynes and Boone is ranked among the largest U.S.-based firms by The National Law Journal, The American Lawyer and The Lawyer. It also was recognized across the board for excellence in the BTI Consulting Group’s 2020 “A-Team” report, which identifies the law firms that in-house counsel commend for providing superior client service.